학술논문

Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
Document Type
article
Source
Biochemistry and Biophysics Reports, Vol 32, Iss , Pp 101348- (2022)
Subject
Neutralisation test
Protein spikes recombinant
in vitro COVID-19 models
Probiotics for COVID-19
IgG sRBD
Biology (General)
QH301-705.5
Biochemistry
QD415-436
Language
English
ISSN
2405-5808
Abstract
Background: There is an urgent need to identify effective therapy to treat coronavirus diseases 2019 (COVID-19). Supplement consumption is becoming popular in this pandemic era. An example of this is probiotic consumption to improve the host's immune system. Objective: This study aimed to prove whether antibodies from people taking probiotics could influence lactate dehydrogenase (LDH), adenosine triphosphate (ATP) values, and cell viability in vitro in peripheral blood mononuclear cells (PBMCs) inoculated with the SARS-CoV-2 spike protein as COVID-19 cells models. Methods: This was an experimental study with control and intervention groups, totally in 12 groups divided based on antibody levels, probiotic intervention, probiotic non-intervention group, SARS-CoV-2 infection group, and non-SARS-CoV-2 infection group. In vitro assays were carried out on PBMC cell cultures inoculated with S1 SARS-CoV-2 recombinant as a COVID-19 cell model. The COVID-19 cell model was given antibodies divided into three antibody level groups: sRBD levels of